Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Tablet Health vs Telos Rx

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #472
Tablet Health

Tablet Health is a DTC telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral forms, with ED and NAD+ wellness lines as well.

Marked down on: States served not published — you must complete the intake quiz to learn eligibility

vs
Dispatch #19Desk pick
Telos Rx

The broadest published catalog in the ranking — compounded GLP-1s plus oral and microdosed tirzepatide, PT-141, intranasal NAD+, and recovery peptides — all compounded and not FDA-approved.

$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks) sema · $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) tirz

Marked down on: Everything is compounded and not FDA-approved — including all peptides and the NAD+ spray

Telos Rx takes this head-to-head with the higher Desk Score, 85/100 (B) against 46/100 (C) for Tablet Health. Tablet Health still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Tablet Health

46/100

C

Overall

Telos Rx

85/100

B

Price transparency

54
74

State access

24
62

Molecule range

51
98

Onboarding speed

53
84

Support responsiveness

56
76

Licensing & trust

41
88

The spec sheet

FieldTablet HealthTelos Rx
SemaglutideNot listed on Tablet Health's site (checked July 25, 2026)$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks)
TirzepatideNot listed on Tablet Health's site (checked July 25, 2026)$139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide)
CoverageNot listed on Tablet Health's site (checked July 25, 2026)Not listed on Telos Rx's site
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forLegitScript-certified GLP-1 with an oral option and named compounders.Patients who want GLP-1 care alongside peptides, NAD+, and sexual-health options on one certified platform, with a needle-free oral or microdosed route.
Desk Score46/100C85/100B

The verdict

Desk pick — Telos Rx

Telos Rx takes this head-to-head with the higher Desk Score, 85/100 (B) against 46/100 (C) for Tablet Health. Tablet Health still holds its ground where its strengths line up with yours.

Choose Tablet Health if…

LegitScript-certified GLP-1 with an oral option and named compounders.

Choose Telos Rx if…

Patients who want GLP-1 care alongside peptides, NAD+, and sexual-health options on one certified platform, with a needle-free oral or microdosed route.

$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks) sema · $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) tirz

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Tablet Health · Telos Rx.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.